We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Siemens Healthineers Showcases Role of Digitalization at AACC 2018

By LabMedica International staff writers
Posted on 31 Jul 2018
At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers (Erlangen, Germany) showcased an array of digital offerings that turn data into actionable information to address a variety of clinical and operational challenges facing laboratories.

Siemens Healthineers provided a preview of the soon-to-be-released Atellica Data Manager that delivers clinical details lab managers need to make informed decisions. More...
Atellica Data Manager operationalizes data from patient samples and QC results to standardize testing, optimize QC performance, and maximize the potential of autoverification while reducing operator interventions, unwarranted variations and errors. Open and scalable, Atellica Data Manager is built on the powerful CentraLink solution currently in use by 1,500+ laboratories in more than 50 countries to help optimize clinical operations, increase testing volumes and improve turnaround times.

At AACC 2018, Siemens Healthineers displayed Atellica Inventory Manager, which provides automated, real-time control over reagents and consumables across multiple lab locations to reduce inventory costs, save time, and improve efficiencies. Pre-labeled radio frequency identification (RFID) tags simplify inventory check-in, checkout, and consumption tracking, and, when enabled, consumables can be ordered automatically through cloud-enabled software.

Also on display at the event was Atellica Process Manager, which in addition to offering laboratories centralized control and visibility, now provides advanced analytics and business intelligence capabilities, enabling labs to gain real-time insight into hidden inefficiencies in their workflow. Out-of-the box and interactive reports enable lab managers to assess key metrics such as turnaround times, testing volumes, problem samples, and automation utilization.

Additionally, the company displayed POCcelerator Data Management System which is designed to address daily point-of-care challenges such as quality control, compliance and operator certification, and offers point-of-care coordinators vendor-neutral, open connectivity to more than 170 devices, giving coordinators visibility into results, quality controls, operators, reagents, and device data. The information is presented in a clear and structured format. Proactive error logs and a traffic-light system indicate potential problems that can be acknowledged with a single click.

Siemens Healthineers demonstrated its investment in transforming healthcare through digital innovations with its Digital Ecosystem. The open and secured cloud environment combines data from lab and imaging devices, which can be leveraged by applications from Siemens Healthineers and other partner companies to provide solutions to the lab. The company also showcased its first lab partner XIFIN and demonstrated how its Revenue Cycle Management solution helps to optimize the laboratory’s financial performance, by identifying potential outreach and outpatient testing reimbursement gaps.

Complementing the company’s digital offerings, Siemens Healthineers featured its Laboratory As A Business (LAAB) Consulting Service designed to address clinical, operational and financial challenges of laboratories, and help position the lab as a decision maker and a powerful contributor to the objectives of value-based care in health systems. LAAB recommends or structures sustainable solutions that help achieve strategic business objectives by leveraging the capabilities of the lab and informatics offerings, expertise, and competencies from Siemens Healthineers.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.